Consultant Ophthalmic Surgeon Specialised in Medical Retina, Ocular Oncology, Cataract and Refractive Surgery, Oculoplastic and Reconstructive Surgery
Research & Publications
DR KONSTANTINOS KOPSIDAS MD PhD FEBO
Publications:
1 | Gatzioufas Z, Kopsidas K, Gyongyossy B, Moschos M, Seitz B. “Late-onset anterior dislocation of a posterior chamber intraocular lens in a patient with pseudoexfoliation syndrome.” Case Rep Ophthalmol. 2011;2(1):11-15. |
2 | Kotoulas A, Kopsidas K, Droutsas K, Grigoriadou M, Bajrami H, Schorderet DF, Petersen MB. “A novel PIKFYVE mutation in fleck corneal dystrophy.” Mol Vis. 2011;17:2776-81. |
3 | Chatziralli IP, Moschos MM, Brouzas D, Kopsidas K, Ladas ID. “Evaluation of retinal nerve fibre layer thickness and visual evoked potentials in optic neuritis associated with multiple sclerosis.” Clin Exp Optom. 2012;95(2):223-8. |
4 | Gatzioufas Z, Stupp T, Moschos M, Kopsidas K, Charalampous P, Thanos S. “Effect of botulinum toxin A on the intraocular pressure and the retina in an animal model.” Cutan Ocul Toxicol. 2013;32(1):40-4. |
5 | Gatzioufas Z, Hafezi F, Kopsidas K, Thanos S. “Dysfunctional uveoscleral pathway in a rat model of congenital glaucoma.” J Physiol Pharmacol. 2013;64(2):161-6. |
6 | Chhabra R, Kopsidas K, Mahmood S. “Accidental insertion of dexamethasone implant into the crystalline lens: 12 months follow-up.” Eye (Lond). 2014;28(5):624-5. |
7 | Kopsidas K, Arora A, Hammamji K, Hay G, Cohen VM, Sagoo MS, Hungerford JL, Plowman PN. “Systemic rituximab for conjunctival marginal zone (MALT) lymphoma is not protective for subsequent disease development in the contralateral eye.” Int J Ophthalmol Clin Res. 2015;2:1-4. |
8 | Bouras K, Kopsidas K, Bariotakis M, Kitsiou P, Kapodistria K, Agrogiannis G, Vergados I, Theodossiadis P, Perrea D. “Effects of dietary supplementation with sea buckthorn (Hippophae rhamnoides L.) seed oil on an experimental model of hypertensive retinopathy in Wistar rats.” Biomed Hub. 2017;2(1):1-9. |
9 | Kopsidas K, Mudhar HS, Sisley K, Hammond DW, Worthington L, Suvarna K, Foran B, Salvi S. “Aggressive ciliary body adenocarcinoma with bilateral lung metastases: histological, molecular, genetic and clinical aspects.” Ocul Oncol Pathol. 2018;4(2):105-10. |
10 | Kopsidas K, Ford R, Ahmed I, Coupland SE. “Concomitant orbital tumours: small lymphocytic lymphoma involving the lacrimal gland of a patient with clinical diagnoses of Muir-Torre syndrome and extensive sebaceous gland carcinoma of the ipsilateral eyelid.” Ocul Oncol Pathol. 2019;5(1):50-4. |
11 | Kopsidas K, Javidi H, Kelly S, Aslam T, Black G, Mahmood S. “Unique case of bilateral exudative retinal detachment following creatine supplementation in a patient with autosomal dominant bestrophinopathy.” Case Rep Ophthalmol. 2019;10(1):89-94. |
12 | Hussain RN, Chiu A, Pittam B, Taktak A, Damato BE, Kacperek A, Errington D, Cauchi P, Chadha V, Connolly J, Salvi S, Rundle P, Cohen V, Arora A, Sagoo MS, Bekir O, Kopsidas K, Heimann H. “Proton beam radiotherapy for choroidal and ciliary body melanoma in the UK—national audit of referral patterns of 1084 cases.” Eye (Lond). 2022;36(5):1035-41. |
13 | Georganta I, Chasapi D, Smith CJ, Kopsidas K, Tatham A. “Systematic review exploring the clinical features of optic neuritis after SARS-CoV infection and vaccination.” BMJ Open Ophthalmol. 2023;8:e001336. doi:10.1136/bmjophth-2023-001336. |
Research Activities
1 | Basic Research on Glaucoma, Optic Nerve Degeneration-Regeneration, and Neuroprotection | Conducted foundational studies in Germany focusing on experimentally induced glaucoma, optic nerve damage and repair mechanisms, and strategies for neuroprotection. |
2 | Doctoral Thesis on Matrix Metalloproteases in Rat Retina | Authored the thesis titled “Investigation of the Expression of Matrix Metalloproteases and Their Inhibitors in the Retina of the Regenerating and Degenerating Optic Nerve of the Rat,” published in the library of the WWU of Münster. |
3 | Clinical Research in Cornea, Electrophysiology, and Glaucoma | Conducted clinical research within specialized departments, including studies on corneal diseases, electrophysiological assessments, and glaucoma management. |
4 | Clinical Investigator in Multicenter and Local Clinical Trials | Participated in several clinical trials: – GMAN (To evaluate the efficacy and safety of intravitreal bevacizumab (Avastin) in patients with neovascular age-related macular degeneration (nAMD)) – RETAIN (Long-term outcomes of ranibizumab treatment in retinal vein occlusion) – COMRADE (Comparative evaluation of aflibercept and ranibizumab in macular edema) – LUMINOUS (Real-world outcomes of ranibizumab treatment in retinal diseases) – MERLOT (Micropulse laser treatment for macular edema due to retinal vein occlusion) – INTREPID (Radiation therapy for wet age-related macular degeneration) |
5 | Ocular Oncology Research on Intra-Tumoral Blood Flow Velocity | Conducted clinical research in ocular oncology, focusing on measuring blood flow velocity within tumors. |
Email:
info@eyestheticon.com